A Phase I Study of Bexarotene and Rosiglitazone in Patients with Refractory Cancers

Publisher： Karger

E-ISSN： 1421-9794|54|3|236-241

ISSN： 0009-3157

Source： Chemotherapy, Vol.54, Iss.3, 2008-06, pp. : 236-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Docetaxel and Bexarotene

By  

Chemotherapy, Vol. 54, Iss. 2, 2008-03 ,pp. : 125-130

Karger

Access to resources Recommend Favorite

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors

By  

Chemotherapy, Vol. 55, Iss. 6, 2009-12 ,pp. : 441-445

Karger

Access to resources Recommend Favorite

Hepatic Arterial Infusion with Irinotecan in Patients with Liver Metastases of Colorectal Cancer: Results of an Extended Phase I Study

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-07 ,pp. : 66-73

Karger

Access to resources Recommend Favorite

Phase I Study of Weekly Irinotecan Combined with Weekly Cisplatin in Patients with Advanced Solid Tumors

By  

Chemotherapy, Vol. 48, Iss. 4, 2002-09 ,pp. : 205-210

Karger

Access to resources Recommend Favorite

Phase I Study of Nedaplatin Prior to S-1 in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 314-318

Karger

Access to resources Recommend Favorite